Bio-IT World Contributed Commentary | Ever since blockchain burst onto the scene a decade ago, people have continually found new—and sometimes odd—applications for the technology. Yet when it comes to the life sciences, a lack of practical applications has resulted in blockchain being considered a "hammer in search of a nail."

NPR.org | There are new concerns about the world's first genetically modified babies. It appears that the genetic variation a Chinese scientist was trying to recreate when he edited twin girls' DNA may be more harmful than helpful to health overall, according to a study published Monday.

Bio-IT World | PerkinElmer has signed on to Accenture's open partner ecosystem and will integrate its big data technology and content into the cloud-based platform's wider efforts in drug discovery and research.

STAT | Could a blood test detect cancer in healthy people? Grail, a Menlo Park, Calif.-based company, has raised $1.6 billion in venture capital to prove the answer is yes.

Bio-IT World | May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including ACD/Labs, Genomenon, Accenture, and more.